MedPath

Diazepam

Drug label sections C16H13ClN2O    M.W. 284.74 Diazepam Tablets USP 2 mg, 5 mg and 10 mg, for oral administration, contain the following inactive ingredients: anhydrous lactose, magnesium stearate and microcrystalline cellulose. Diazepam Tablets USP 5 mg also contain D&C Yellow No. 10. Diazepam Tablets USP 10 mg also contain FD&C Blue No. 1.

Approved
Approval ID

0fab9e5b-395c-4b32-bbad-3e23b4059d2b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 2, 2010

Manufacturers
FDA

RedPharm Drug Inc.

DUNS: 008039641

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

diazepam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67296-0506
Application NumberANDA071135
Product Classification
M
Marketing Category
C73584
G
Generic Name
diazepam
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 12, 2010
FDA Product Classification

INGREDIENTS (4)

diazepamActive
Quantity: 5 mg in 1 1
Code: Q3JTX2Q7TU
Classification: ACTIB
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
anhydrous lactoseInactive
Code: 3SY5LH9PMK
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diazepam - FDA Drug Approval Details